Functional analyses indicated that overexpression of SIRT5 can inhibit gastric cancer cell growth both in vitro and in vivo by arresting the cell cycle at the G1/S phase and suppressing migration and invasion via modulation of epithelial-mesenchymal transition (EMT). Here, SIRT5 is linked to gastric cancer.